How did the Sonic Healthcare (ASX:SHL) share price respond last earnings season?

The ASX 200 healthcare company will report its full year results tomorrow.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sonic Healthcare Limited (ASX: SHL) share price gained 4% last week.

That compares to a loss of 2% on the S&P/ASX 200 Index (ASX: XJO).

The ASX 200 healthcare share will be closely watched tomorrow, when the company releases its results for the financial year ending 30 June 2021.

With that in mind, we take a look back to see how Sonic Healthcare's shares responded following last year's results.

Three healthcare workers look and point at at medical image

Image source: Getty Images

What did Sonic report for FY20?

On 20 August 2020, The Motley Fool reported that Sonic Healthcare's share price hit a record "after its profit results allayed a key concern of its critics".

Here are some of the key numbers that Sonic released for FY20:

  • Group revenue increased 11% to $6.86 billion
  • Underlying net profit increased 7% to $552 million
  • Operating cash flow increased 26% to $1 billion
  • Final dividend declared of 51 cents per share; total FY20 dividend increased 1.2% year-on-year

The company defied naysayers who'd been concerned that one of its core revenue drivers – routine screening and diagnostics – would be hobbled by the pandemic as people delayed visiting medical facilities for regular checkups.

While that segment of the company's business did take a hit, a surge in coronavirus testing managed to help deliver the 11% boost to revenue.

How has Sonic Healthcare's share price performed since then?

Since market open on the day after it deliver its FY20 results, Sonic has gained 24%. By comparison the ASX 200 is up 22% in that same time.

Year-to-date the Sonic Healthcare share price has surged 31% in 2021.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Businesswoman with a pleased smile reading on her laptop at a desk in the office with a look of satisfaction.
Healthcare Shares

Are CSL shares dirt cheap and a strong buy?

There is plenty for CSL to prove next week. The current valuation is why I am still interested.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Why this ASX healthcare stock is a top rebound candidate with big upside 

This could be a perfect buy-low candidate.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

2 ASX healthcare stocks tipped to return 34% to 63%

These companies could be poised for much bigger things.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
ASX Share Market News

Are Pro Medicus shares now too cheap to ignore?

The discount looks tempting, but slowing growth could expose valuation risks.

Read more »

Two ASX share investors sharing a secret.
Healthcare Shares

Cochlear shares are quietly rebounding: Is a bigger rally coming?

After a 58% plunge, Cochlear doesn’t need perfection to surprise investors.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

This ASX biotech is tipped to more than double in value

Encouraging trial results have the analysts excited.

Read more »

person climbing mountain
Healthcare Shares

CSL share price forecast: How high could it climb in the next year?

CSL shares could roar back, but investors need more than hope.

Read more »

Two CEOs shaking hands on a deal.
Healthcare Shares

Integral Diagnostics: FY26 results and new CFO appointment

Integral Diagnostics delivered double-digit profit growth and appointed a new CFO.

Read more »